Type One Diabetes Completed Phase 2 Trials for Glucagon (DB00040)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02018627	Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon	Treatment	Glucagon (DB00040)
NCT02798250	Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2	Treatment	Glucagon (DB00040) Insulin human (DB00030)
NCT02416765	Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes	Treatment	Glucagon (DB00040) Insulin aspart (DB01306) Insulin human (DB00030)
NCT00797823	Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone	Treatment	Glucagon (DB00040) Insulin aspart (DB01306) Insulin human (DB00030) Sodium chloride (DB09153)
NCT02626936	Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation	Treatment	Glucagon (DB00040) Insulin human (DB00030)
NCT02971228	Feasibility Trial Testing the Bionic Pancreas With ZP4207	Treatment	Dasiglucagon (DB15226) Glucagon (DB00040) Insulin lispro (DB00046)
NCT02916251	ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon	Treatment	Dasiglucagon (DB15226) Glucagon (DB00040)
NCT02411578	Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia	Treatment	Glucagon (DB00040)
NCT01997411	Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes	Treatment	Glucagon (DB00040)
NCT02660242	The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes	Prevention	Glucagon (DB00040)